Specific codes in ICD-10 are unique alphanumeric designations used to identify and categorize diseases, disorders, and conditions. They consist of 3-5 characters, including both letters and numbers, that provide a high level of detail and specificity.
| Language | Translation |
|---|---|
|
|
Zygomycosis |
|
|
Zygomycose |
| Level | Code | Title | |
|---|---|---|---|
| 1 | I | Certain infectious and parasitic diseases | |
| 2 | B35-B49 | Mycoses | |
| 3 | B46 | Zygomycosis |
| Code | Title | |
|---|---|---|
| B46.0 | Pulmonary mucormycosis | |
| B46.1 | Rhinocerebral mucormycosis | |
| B46.2 | Gastrointestinal mucormycosis | |
| B46.3 | Cutaneous mucormycosis | |
| B46.4 | Disseminated mucormycosis | |
| B46.5 | Mucormycosis, unspecified | |
| B46.8 | Other zygomycoses | |
| B46.9 | Zygomycosis, unspecified |
| Active Ingredient |
|---|
|
Amphotericin B is a macrocyclic, polyene antifungal antibiotic produced by Streptomyces nodosus. The molecule is thought to act by binding to sterols in the fungal cell membrane, with a resulting change in membrane permeability, allowing leakage of a variety of small molecules. |
|
Diflucortolone is a topically acting fluoridated corticosteroid which suppresses inflammation in inflammatory and allergic skin conditions and alleviates the subjective complaints such as itching, burning and pain. |
|
Minocycline is a semi-synthetic derivative of tetracycline. Minocycline inhibits protein synthesis in susceptible bacteria. In common with other tetracyclines it is primarily bacteriostatic and has a similar spectrum of activity to other tetracyclines. |